By Meryl Nass, MD | September 23, 2021 Last Friday, FDA’s advisory committee (VRBPAC) voted 16 to 2 against giving a license to a third Pfizer booster shot for everyone age 16 and up. Although a second vote at Friday’s meeting had not been planned, another question was hastily developed. That question asked whether the vaccine […]
Source